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CLINICAL USE OF BIKLIN IN COMPLICATED
     URINARY TRACT INFECTIONS
・Hidetoshi FuKATsu， Akio SEGAwA， Haehiro SENDA，
    Yoshimasa HAyAsE and Chu OGAwA
   From the Department of Urolog．v． Aichi Medical School
       （Director： Prof． A． Segawa， M． D．？
  In 15 patients， in which the urinary infection due to Pseudomonas or Proteus was found during
the indwelling catheter， arnong the patients hospitalized in the Department of Urology of AICHI
MEDICAL SCHOOL in a period of 4 months frem June to September 1977， we studied the clinical
effect．and the side effects．with Biklip， and obtained the ’following results．
  1） Remarl〈able effect ill 8， good effect in 2 and no effect in 2 out of 12 cases with infection due
to Pseudomonas． ．Rate otf efficacy was 10／！2 or 83．3％．
  2） Remarkable effect in 3 out ef 3 cases with infection due to Proteus， （IOOOfi，）．
  3） Out Qf the total cases， the remarkable effect was obtained in l i cases， the good effe¢t in 2
cases， and， no effect in 2 cases， arid the rate of eficacy was 13／15 or 83．79／0．
  4） For the side effects， we examined specially the influences on the renal function， the hepatic
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Table 1． Summary of patients treated with AMK．
Case
N”6J Age Sex Diagnosisい砦臨一階騰轡，，e，Organism （count／ml｝   ボpost．  AMK  GM
5ens蹴vi世y｛disc）         Side     EHect
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＊： Before the treatment， ＊＊： After the treatment
Table 2． Efllcacy on each species．



























Table 3． Disc sensitivity test （AMK）．
  Sensitivity


















 ノワro fθus 21
2 12
   5
TotG16  6  1 2 15
Table 4． Disc sensitivity test （C－M）；
  Sensi十ivity




   5
Tota19  4 2 15









 GOT， GPT， alkaline phosphatase 1こついて調べて
みたが，投与前後の値に著変はみられなかった．
 3） 末梢血液像におよぼす影響について




Table 5． Biochemical examination．
Hematology Liver functionRenal function
Case RBC（X］O‘） WBC（XIOb H b．GOT GPT ・Al－P BUN Creatinine
















80  70 iL4 日．5  11
62 55 12，一2．5 16
55 47 12．5 12，4 14
88 64 10，5 ll，2 9
98 76 ll．7 IO．9 2S
56 62 12．7 12，5 i4
7  82 1L9 口．7  ｝8
85 82 10．7 IO．5 73
66 61 IO．8 IO．O 15
52 47 9．4 9．1 16
65 61 ］O．8 10，9 22
94 97 ILO 122 ］2
86 72 12，8 IZ2 51
57 59 ］L2 12，5 22
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かった．また，BUN， creatinine， GOT， GPT， alkaline
phosphatase， RBC， WB〔】， Hbなどの値にも著変はみ
られなかった．
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